These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Outcomes Following Transcatheter Aortic Valve Replacement for Degenerative Stentless Versus Stented Bioprostheses. Duncan A; Moat N; Simonato M; de Weger A; Kempfert J; Eggebrecht H; Walton A; Hellig F; Kornowski R; Spargias K; Mendiz O; Makkar R; Guerrero M; Rihal C; George I; Don C; Iadanza A; Bapat V; Welsh R; Wijeysundera HC; Wood D; Sathananthan J; Danenberg H; Maisano F; Garcia S; Gafoor S; Nombela-Franco L; Cobiella J; Dvir D JACC Cardiovasc Interv; 2019 Jul; 12(13):1256-1263. PubMed ID: 31202944 [TBL] [Abstract][Full Text] [Related]
26. Equipment entrapment during redo-TAVR with successful BASILICA procedure. Qureshi WT; Parker M; Walker J; Kakouros N Catheter Cardiovasc Interv; 2021 Aug; 98(2):E320-E323. PubMed ID: 33484070 [TBL] [Abstract][Full Text] [Related]
27. Redo-aortic valve replacement in prior stentless prosthetic aortic valves: Transcatheter versus surgical approach. Choi CH; Cao K; Malaver D; Kincaid EH; Lata A; Kon N; Belford PM; Gandhi SK; Applegate RJ; Zhao DXM Catheter Cardiovasc Interv; 2022 Jan; 99(1):181-192. PubMed ID: 34402588 [TBL] [Abstract][Full Text] [Related]
28. Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial. Douglas PS; Leon MB; Mack MJ; Svensson LG; Webb JG; Hahn RT; Pibarot P; Weissman NJ; Miller DC; Kapadia S; Herrmann HC; Kodali SK; Makkar RR; Thourani VH; Lerakis S; Lowry AM; Rajeswaran J; Finn MT; Alu MC; Smith CR; Blackstone EH; JAMA Cardiol; 2017 Nov; 2(11):1197-1206. PubMed ID: 28973520 [TBL] [Abstract][Full Text] [Related]
29. Balloon Fracturing Valve-in-Valve: How to Do It and a Case Report of TAVR in a Rapid Deployment Prosthesis. Saadi RP; Tagliari AP; Polanczyck CA; Ferreira Leal JC; Saadi EK J Interv Cardiol; 2022; 2022():4368887. PubMed ID: 35600211 [TBL] [Abstract][Full Text] [Related]
30. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure. Barbanti M; Webb JG; Tamburino C; Van Mieghem NM; Makkar RR; Piazza N; Latib A; Sinning JM; Won-Keun K; Bleiziffer S; Bedogni F; Kapadia S; Tchetche D; Rodés-Cabau J; Fiorina C; Nombela-Franco L; De Marco F; de Jaegere PP; Chakravarty T; Vaquerizo B; Colombo A; Svensson L; Lange R; Nickenig G; Möllmann H; Walther T; Della Rosa F; Elhmidi Y; Dvir D; Brambilla N; Immè S; Sgroi C; Gulino S; Todaro D; Pilato G; Petronio AS; Tamburino C Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578840 [TBL] [Abstract][Full Text] [Related]
32. What is the best approach in a patient with a failed aortic bioprosthetic valve: transcatheter aortic valve replacement or redo aortic valve replacement? Tourmousoglou C; Rao V; Lalos S; Dougenis D Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):837-43. PubMed ID: 25754372 [TBL] [Abstract][Full Text] [Related]